{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-03-18",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "country": "United States",
      "city": "Indiana",
      "address_1": "625 Kolter Dr Ste 4",
      "reason_for_recall": "CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.",
      "address_2": "",
      "product_quantity": "21 bottles of 90 = 1890 tablets",
      "code_info": "Lot # B0335344-081717, exp. date 08/2018  Lot # B0363364-110917, exp. date 11/2018  Lot # B0391225-012218, exp. date 01/2019  Lot # B0408458-030618, exp. date 03/2019  Lot # B0384871-010318, exp. date 01/2019  Lot # B0436862-051518, exp. date 05/2019",
      "center_classification_date": "20180816",
      "distribution_pattern": "Product was distributed to three customers in FL and VA.",
      "state": "PA",
      "product_description": "Valsartan 160 mg Tablets, HDPE 90 cc bottles in cardboard trays, Rx Only, RemedyRepack, Inc., 625 Kolter Drive, Suite 4, Indiana, PA 15701,   NDC: 61786-0792-19",
      "report_date": "20180822",
      "classification": "Class II",
      "openfda": {},
      "recalling_firm": "RemedyRepack Inc.",
      "recall_number": "D-1101-2018",
      "initial_firm_notification": "Letter",
      "product_type": "Drugs",
      "event_id": "80827",
      "termination_date": "20181012",
      "more_code_info": "",
      "recall_initiation_date": "20180810",
      "postal_code": "15701-3571",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "status": "Terminated"
    }
  ]
}